Session Learning Objectives:
1. Understand major shifts in the treatment paradigm for children with systemic lupus erythematosus;
2. Recognize treatment toxicities and impact of therapies on long-term outcomes;
3. Identify major barriers to improving care for children with lupus.

Presenter:
Joyce Chang, MD, MSCE
Attending Physician
Rheumatology Program
Boston Children’s Hospital

Dr. Chang does plan on discussing unlabeled/investigational uses of a commercial product: Obinutuzumab; anti-CD19 chimeric antigen receptor-T cells (generically).

Session date: 
05/01/2025 - 12:00pm to 1:00pm EDT
Location: 
Zoom and in person
850 Harrison Avenue
Yawkey B
Boston, MA 02118
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation
Please login or register to take this course.